Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant hereditary cancer
syndrome caused by missense gain-of-function mutations in the RET proto-oncogene on …

Unlike daily routine images, ultrasound images are usually monochrome and low-resolution.
In ultrasound images, the cancer regions are usually blurred, vague margin and irregular in …

Progress in the treatment of advanced medullary thyroid cancer (MTC) has resulted from the
approval of 2 drugs within the past 5 years, vandetanib and cabozantinib. These multikinase …

This study aimed to identify circulating miRNAs as novel non-invasive biomarkers for
prognosis and vandetanib response in advanced medullary thyroid cancer (MTC) patients …

Purpose The long non-coding RNA GAS8 antisense RNA 1 (lncRNA GAS8-AS1) is a tumor
suppressor in papillary thyroid cancer (PTC), but the mechanisms underlying how GAS8 …

Background Medullary thyroid carcinoma (MTC) originates from calcitonin‐producing cells
of the thyroid. In 2009, we published our first report on the biological characteristics and …

Recent studies have shown a significant increase in the temporal trend of medullary thyroid
carcinoma (MTC) incidence. However, it remains unknown to which extent sporadic …

Background and Objectives We aimed to evaluate the disease specific‐survival (DSS) of
patients with Medullary Thyroid Cancer (MTC) confined to the central neck based on the …

Background: The widespread use of neck sonography in recent years has led to a dramatic
increase in the detection of thyroid cancer, accompanied by changes in the clinicopathologic …

Background Glucagon‐like peptide‐1 receptor agonists, such as dulaglutide, exenatide and
liraglutide, are approved to treat Type 2 diabetes mellitus. Although these drugs provide …